Back to search

Article

A multiomics signature highlights alterations underlying homologous recombination deficiency in triple-negative breast cancer

2022-01-18

Abstract excerpt

<h4>Background: </h4> Homologous recombination (HR) is a key pathway in DNA double-strand damage repair. HR deficiency (HRD) more commonly occurs in triple-negative breast cancers (TNBCs) than in other breast cancer subtypes. Several clinical trials have demonstrated the value of HRD in stratifying breast cancer patients into distinct response groups to poly ADP ribose polymerase (PARP) inhibitors and chemotherapy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
561670b3-982b-5e82-99ab-c1ca1924b4b9
DOI
10.21203/rs.3.rs-1244930/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A multiomics signature highlights alterations underlying homologous recombination deficiency in triple-negative breast cancerDOI 10.21203/rs.3.rs-1244930/v1
Select a neighboring publication to make it the new centre.